Affiliation: University of Pennsylvania
- Battling AIDS in America: an evaluation of the National HIV/AIDS StrategyBaligh Yehia
Division of Infectious Disease, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
Am J Public Health 101:e4-8. 2011..With ambitious five-year targets set for each goal, the NHAS requires significant fiscal investment to achieve its desired impact on the domestic HIV epidemic...
- Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adultsBaligh R Yehia
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, 19104, USA
Clin Infect Dis 55:593-9. 2012..Prior research suggests that ART medication errors are on the rise in US hospitals. This analysis provides a current estimate of inpatient antiretroviral prescribing errors...
- Comparing different measures of retention in outpatient HIV careBaligh R Yehia
Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
AIDS 26:1131-9. 2012..There is no gold standard to measure retention in care. This study is the first to compare different measures of retention, using a large geographically diverse sample...
- Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptionsBaligh R Yehia
Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA
AIDS Care 24:769-77. 2012..Patients without a healthy fear of transitioning from ART-RCTs to routine care may be at increased risk of viral failure. Focus should be given to assisting patients during this transition...
- Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapyB R Yehia
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
HIV Med 12:535-43. 2011..Few data exist on the incidence of and risk factors for bacteraemia across time in the current era of highly active antiretroviral therapy (HAART)...